Business Context and Reporting Period
Company: CollPlant Biotechnologies Ltd.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Date: March 25, 2022
Context: The filing announces the scheduling of an Annual and Extraordinary General Meeting of Shareholders to be held on May 2, 2022, in Tel-Aviv, Israel. The document serves to provide the Notice and Proxy Statement and a Proxy Card to shareholders.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a procedural filing regarding a shareholder meeting and does not contain financial statements or performance data.
Material Changes
No material financial changes versus a prior comparable period are reported in this document.
Guidance, Outlook, and Management Commentary
Shareholder Meeting Details:
- Date: May 2, 2022
- Time: 10:00 a.m. Israel time
- Location: Gross & Co. law firm, One Azrieli Center, Round Building, 40th Floor, Tel-Aviv, Israel
- Exhibit 99.1: Notice and Proxy Statement describing proposals and voting procedures.
- Exhibit 99.2: Proxy Card for voting without attending in person.
Key Facts for Investor Verification
- Verify the specific proposals to be voted upon in the attached Notice and Proxy Statement (Exhibit 99.1).
- Confirm the record date for shareholder eligibility, which is not explicitly stated in this summary text but is contained in the attached exhibits.
- Review the voting procedures for in-person attendance versus proxy voting.
- Note that this filing does not contain updated financial results; investors should refer to the most recent Form 20-F or quarterly reports for financial data.